Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MAGS vs GSK✓SelectedUSD · GSKMAGS vs GSK performance historyLatest closeAs of-5.18%11/20
Stock and ETF performance explorer

MAGS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+158.9%
GSK return
+46.1%
Excess return
+112.8%
Maximum drawdown
-29.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.2%-0.1%-5.1%-5.2%
7D-10.2%-5.3%-4.9%-10.2%
30D-15.4%-3.7%-11.7%-15.4%
3M-7.8%-7.3%-0.6%-7.8%
6M-11.3%-4.2%-7.0%-11.2%
YTD-6.5%+0.9%-7.4%-6.3%
1Y-0.6%+7.3%-7.9%-0.4%
3Y+91.8%+52.7%+39.1%+90.5%
All+158.9%+46.1%+112.8%+156.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling